Dynavax Technologies - Stock Price History | DVAX

Historical daily share price chart and data for Dynavax Technologies since 2020 adjusted for splits. The latest closing stock price for Dynavax Technologies as of March 31, 2020 is 3.53.
  • The all-time high Dynavax Technologies stock closing price was 98.50 on December 11, 2006.
  • The Dynavax Technologies 52-week high stock price is 8.19, which is 132% above the current share price.
  • The Dynavax Technologies 52-week low stock price is 1.80, which is 49% below the current share price.
  • The average Dynavax Technologies stock price for the last 52 weeks is 4.88.
Dynavax Technologies Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 6.1580 9.4500 12.0900 2.6900 5.7200 -37.49%
2018 14.7785 18.8000 20.7500 8.1400 9.1500 -51.07%
2017 11.8018 4.0500 24.0750 3.8000 18.7000 373.42%
2016 14.7131 23.1500 29.7000 3.9000 3.9500 -83.65%
2015 23.6379 17.4100 31.6800 16.0000 24.1600 43.30%
2014 15.7874 19.9000 20.7000 13.0000 16.8600 -13.98%
2013 18.6199 29.2000 33.3000 10.1000 19.6000 -31.23%
2012 40.2482 32.8000 52.6000 24.4000 28.5000 -14.16%
2011 27.1563 30.9000 35.3000 18.2000 33.2000 3.75%
2010 18.1281 14.4000 32.0000 12.7000 32.0000 125.35%
2009 12.5715 7.8990 25.5000 5.1000 14.2000 69.05%
2008 22.2934 52.5000 65.5000 1.5100 8.4000 -83.56%
2007 48.6636 84.7000 87.9000 36.7000 51.1000 -44.34%
2006 55.9188 42.9000 98.5000 36.4000 91.8000 118.05%
2005 53.6628 77.9000 79.9000 35.9000 42.1000 -47.38%
2004 66.9763 94.0000 94.0000 41.8000 80.0000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.307B $0.035B
Dynavax Technologies discovers, develops, and intends to commercialize innovative products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using versatile, proprietary approaches that alter immune system responses in highly specific ways. Dynavax's clinical development programs are based on immunostimulatory sequences which are short DNA sequences that enhance the ability of the immune system to fight disease and control chronic inflammation.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $122.963B 14.06
Gilead Sciences (GILD) United States $95.597B 12.37
CSL (CSLLY) Australia $87.858B 0.00
Vertex Pharmaceuticals (VRTX) United States $60.130B 54.57
Biogen (BIIB) United States $55.027B 9.40
Regeneron Pharmaceuticals (REGN) United States $52.039B 22.04
Illumina (ILMN) United States $40.606B 41.98
Seattle Genetics (SGEN) United States $19.860B 0.00
Alexion Pharmaceuticals (ALXN) United States $19.380B 8.99
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.120B 0.00
Incyte (INCY) United States $15.645B 33.57
BioMarin Pharmaceutical (BMRN) United States $14.842B 634.54
BioNTech SE (BNTX) Germany $14.028B 0.00
Genmab (GNMSF) Denmark $12.332B 39.66
Galapagos (GLPG) Belgium $12.312B 26.89
Alnylam Pharmaceuticals (ALNY) United States $12.306B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.513B 49.14
Moderna (MRNA) United States $10.028B 0.00
QIAGEN (QGEN) Netherlands $9.217B 28.10
Exact Sciences (EXAS) United States $8.646B 0.00
BeiGene (BGNE) Cayman Islands $8.167B 0.00
Sarepta Therapeutics (SRPT) United States $7.663B 0.00
Bio-Techne Corp (TECH) United States $7.317B 50.08
Guardant Health (GH) United States $6.725B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.419B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.581B 14.75
Ascendis Pharma (ASND) Denmark $5.538B 0.00
Exelixis (EXEL) United States $5.427B 17.42
Reata Pharmaceuticals (RETA) United States $5.379B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.069B 0.00
Repligen (RGEN) United States $4.991B 91.26
Amarin (AMRN) Ireland $4.851B 0.00
Acceleron Pharma (XLRN) United States $4.561B 0.00
China Biologic Products (CBPO) China $4.276B 25.38
Vir Biotechnology (VIR) United States $3.898B 0.00
Mirati Therapeutics (MRTX) United States $3.576B 0.00
Adaptive Biotechnologies (ADPT) United States $3.426B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.371B 0.00
MorphoSys AG (MOR) Germany $3.357B 0.00
Global Blood Therapeutics (GBT) United States $3.166B 0.00
Blueprint Medicines (BPMC) United States $3.132B 0.00
Zai Lab (ZLAB) China $3.078B 0.00
Immunomedics (IMMU) United States $2.944B 0.00
NeoGenomics (NEO) United States $2.905B 125.96
Emergent Biosolutions (EBS) United States $2.834B 19.67
CRISPR Therapeutics AG (CRSP) Switzerland $2.695B 45.66
Genmab (GMAB) Denmark $2.637B 10.34
Bluebird Bio (BLUE) United States $2.612B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.566B 0.00
Halozyme Therapeutics (HALO) United States $2.510B 0.00
Amicus Therapeutics (FOLD) United States $2.498B 0.00
MyoKardia (MYOK) United States $2.394B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.332B 0.00
Alkermes (ALKS) Ireland $2.272B 180.00
RA PHARMCTL INC (RARX) United States $2.241B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.136B 0.00
Arena Pharmaceuticals (ARNA) United States $2.116B 5.51
Denali Therapeutics (DNLI) United States $2.077B 0.00
UniQure (QURE) Netherlands $1.993B 0.00
Principia Biopharma (PRNB) United States $1.978B 0.00
Viela Bio (VIE) United States $1.938B 0.00
Alector (ALEC) United States $1.924B 0.00
Eidos Therapeutics (EIDX) United States $1.883B 0.00
Fate Therapeutics (FATE) United States $1.759B 0.00
Epizyme (EPZM) United States $1.666B 0.00
Zymeworks (ZYME) Canada $1.633B 0.00
Arvinas (ARVN) United States $1.606B 0.00
Insmed (INSM) United States $1.540B 0.00
Akcea Therapeutics (AKCA) United States $1.486B 31.96
Dicerna Pharmaceuticals (DRNA) United States $1.322B 0.00
REGENXBIO (RGNX) United States $1.253B 0.00
Coherus BioSciences (CHRS) United States $1.186B 14.11
Ligand Pharmaceuticals (LGND) United States $1.175B 36.52
Inovio Pharmaceuticals (INO) United States $1.169B 0.00
Twist Bioscience (TWST) United States $1.141B 0.00
Zealand Pharma (ZEAL) Denmark $1.120B 0.00
Editas Medicine (EDIT) United States $1.111B 0.00
Myriad Genetics (MYGN) United States $1.082B 19.09
NextCure (NXTC) United States $1.016B 0.00
PHARMA MAR SA (PHMMF) Spain $0.941B 0.00
NGM Biopharmaceuticals (NGM) United States $0.894B 0.00
Beam Therapeutics (BEAM) United States $0.894B 0.00
Zealand Pharma (ZLDPF) Denmark $0.881B 0.00
Intra-Cellular Therapies (ITCI) United States $0.876B 0.00
Adverum Biotechnologies (ADVM) United States $0.876B 0.00
Revance Therapeutics (RVNC) United States $0.875B 0.00
Cytokineticsorporated (CYTK) United States $0.760B 0.00
Sangamo Therapeutics (SGMO) United States $0.754B 0.00
Novavax (NVAX) United States $0.737B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.730B 0.00
Kadmon Holdings (KDMN) United States $0.706B 0.00
Athenex (ATNX) United States $0.664B 0.00
Frequency Therapeutics (FREQ) United States $0.650B 0.00
Codexis (CDXS) United States $0.642B 0.00
Pharming Group (PHGUF) Netherlands $0.632B 0.00
Intellia Therapeutics (NTLA) United States $0.620B 0.00
Cara Therapeutics (CARA) United States $0.620B 0.00
Retrophin (RTRX) United States $0.614B 0.00
Arcus Biosciences (RCUS) United States $0.612B 0.00
Bellus Health (BLU) Canada $0.606B 0.00
GENFIT S.A (GNFT) France $0.567B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.566B 0.00
Intrexon (PGEN) United States $0.553B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.543B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.533B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.519B 4.56
Compugen (CGEN) Israel $0.519B 0.00
Castle Biosciences (CSTL) United States $0.496B 0.00
AC Immune SA (ACIU) Switzerland $0.493B 12.59
ANI Pharmaceuticals (ANIP) United States $0.491B 8.85
Clovis Oncology (CLVS) United States $0.472B 0.00
Mesoblast (MESO) Australia $0.466B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
MeiraGTx Holdings (MGTX) United States $0.459B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.458B 0.00
Morphic Holding (MORF) United States $0.446B 0.00
DBV Technologies S.A (DBVT) France $0.445B 0.00
Heska (HSKA) United States $0.443B 0.00
Cel-Sci (CVM) United States $0.433B 0.00
Athersys (ATHX) United States $0.425B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.425B 0.00
Prothena (PRTA) Ireland $0.424B 0.00
Vericel (VCEL) United States $0.415B 61.60
Scholar Rock Holding (SRRK) United States $0.414B 0.00
Verastem (VSTM) United States $0.406B 0.00
Anika Therapeutics (ANIK) United States $0.404B 13.92
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.400B 0.00
MiMedx (MDXG) United States $0.397B 0.00
Agenus (AGEN) United States $0.388B 0.00
AnaptysBio (ANAB) United States $0.386B 0.00
Cellectis S.A (CLLS) France $0.384B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.383B 0.00
UROGEN PHARMA (URGN) United States $0.379B 0.00
Cue Biopharma (CUE) United States $0.365B 0.00
Merus (MRUS) Netherlands $0.364B 0.00
BioDelivery Sciences (BDSI) United States $0.359B 41.44
Adaptimmune Therapeutics (ADAP) United Kingdom $0.358B 0.00
PDL BioPharma (PDLI) United States $0.352B 10.56
Sorrento Therapeutics (SRNE) United States $0.335B 0.00
Puma Biotechnology (PBYI) United States $0.328B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.321B 0.00
WAVE Life Sciences (WVE) Singapore $0.318B 0.00
Precision BioSciences (DTIL) United States $0.318B 0.00
NantKwest (NK) United States $0.309B 0.00
CytomX Therapeutics (CTMX) United States $0.305B 0.00
Pfenex (PFNX) United States $0.300B 439.00
Mersana Therapeutics (MRSN) United States $0.298B 0.00
Cellular Biomedicine (CBMG) United States $0.293B 0.00
Kala Pharmaceuticals (KALA) United States $0.289B 0.00
Avid Bioservices (CDMO) United States $0.278B 0.00
Seres Therapeutics (MCRB) United States $0.263B 0.00
Kamada (KMDA) Israel $0.256B 10.67
ADMA Biologics Inc (ADMA) United States $0.248B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.244B 0.00
Albireo Pharma (ALBO) United States $0.243B 0.00
Stemline Therapeutics (STML) United States $0.240B 0.00
Sutro Biopharma (STRO) United States $0.237B 0.00
Syros Pharmaceuticals (SYRS) United States $0.235B 0.00
Geron (GERN) United States $0.230B 0.00
MannKind (MNKD) United States $0.229B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.226B 0.00
Gritstone Oncology (GRTS) United States $0.212B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.211B 0.00
Selecta Biosciences (SELB) United States $0.205B 0.00
Aduro Biotech (ADRO) United States $0.204B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.201B 1.81
Alcobra (ARCT) United States $0.201B 0.00
XOMA (XOMA) United States $0.197B 0.00
Protagonist Therapeutics (PTGX) United States $0.196B 0.00
ChromaDex (CDXC) United States $0.188B 0.00
HOOKIPA Pharma (HOOK) United States $0.182B 0.00
OSMOTICA PHARM (OSMT) United States $0.176B 0.00
IVERIC Bio (ISEE) United States $0.174B 0.00
Abeona Therapeutics (ABEO) United States $0.171B 0.00
Starpharma Holdings (SPHRY) Australia $0.168B 0.00
VBI Vaccines (VBIV) United States $0.168B 0.00
Spero Therapeutics (SPRO) United States $0.163B 0.00
Biofrontera AG (BFRA) Germany $0.159B 0.00
Prometic Life Sciences (LMNL) Canada $0.156B 0.00
Kindred Biosciences (KIN) United States $0.154B 0.00
Aytu Bioscience (AYTU) United States $0.153B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.153B 0.00
POXEL SA FRANCE (PXXLF) France $0.145B 0.00
Liquidia Technologies (LQDA) United States $0.140B 0.00
Fortress Biotech (FBIO) United States $0.140B 0.00
Cerecor (CERC) United States $0.138B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.136B 0.00
Windtree Therapeutics (WINT) United States $0.136B 0.00
VolitionRX (VNRX) United States $0.134B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.132B 0.00
Dyadic (DYAI) United States $0.131B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.126B 0.00
Antibe Therapeutics (ATBPF) Canada $0.125B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.124B 4.88
VTv Therapeutics (VTVT) United States $0.123B 0.00
Affimed (AFMD) Germany $0.123B 0.00
Theratechnologies (THTX) Canada $0.121B 0.00
Exicure (XCUR) United States $0.119B 0.00
Enzo Biochem (ENZ) United States $0.119B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.114B 0.00
IBio (IBIO) United States $0.113B 0.00
Celyad SA (CYAD) Belgium $0.113B 0.00
AIT Therapeutics (XAIR) United States $0.108B 0.00
Palatin Technologies (PTN) United States $0.105B 2.88
Strongbridge Biopharma (SBBP) United States $0.103B 0.00
Aptinyx (APTX) United States $0.102B 0.00
Northwest Biotherapeutics (NWBO) United States $0.102B 0.00
PHASEBIO PHARMA (PHAS) United States $0.098B 0.00
Cidara Therapeutics (CDTX) United States $0.097B 0.00
OvaScience (MLND) United States $0.096B 0.00
CorMedix Inc (CRMD) United States $0.093B 0.00
TELA Bio (TELA) United States $0.092B 0.00
Five Prime Therapeutics (FPRX) United States $0.088B 0.00
Checkpoint Therapeutics (CKPT) United States $0.083B 0.00
ARAVIVE, INC (ARAV) United States $0.083B 0.00
Clearside Biomedical (CLSD) United States $0.079B 0.00
Arbutus Biopharma (ABUS) Canada $0.077B 0.00
Cyclerion Therapeutics (CYCN) United States $0.076B 0.00
Happiness Biotech Group (HAPP) China $0.074B 0.00
Pluristem Therapeutics (PSTI) Israel $0.074B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.073B 0.00
Eton Pharmaceuticals (ETON) United States $0.072B 0.00
Adocia (ADOCY) France $0.066B 0.00
Vaccinex (VCNX) United States $0.066B 0.00
Emmaus Life Sciences (EMMA) United States $0.065B 0.00
Menlo Therapeutics (MNLO) United States $0.064B 0.00
Proteostasis Therapeutics (PTI) United States $0.064B 0.00
SESEN BIO, INC (SESN) United States $0.061B 0.00
Orgenesis (ORGS) United States $0.061B 3.56
Applied Genetic Technologies (AGTC) United States $0.060B 0.00
Synlogic (SYBX) United States $0.059B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.057B 0.00
Trevena (TRVN) United States $0.057B 0.00
Catalyst Biosciences (CBIO) United States $0.054B 0.00
AquaBounty Technologies (AQB) United States $0.054B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.052B 0.00
Vascular Biogenics (VBLT) Israel $0.048B 0.00
Acorda Therapeutics (ACOR) United States $0.047B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.047B 0.00
Idera Pharmaceuticals (IDRA) United States $0.043B 0.00
Organovo Holdings (ONVO) United States $0.037B 0.00
Lumos Pharma (LUMO) United States $0.037B 0.00
AmpliPhi Biosciences (ARMP) United States $0.036B 0.00
Soligenix (SNGX) United States $0.036B 0.00
Protalix BioTherapeutics (PLX) Israel $0.035B 0.00
CollPlant Holdings (CLGN) Israel $0.034B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.034B 0.00
Cocrystal Pharma (COCP) United States $0.034B 0.00
Advaxis (ADXS) United States $0.033B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.032B 0.00
DiaMedica Therapeutics (DMAC) United States $0.031B 0.00
Prima BioMed (IMMP) Australia $0.030B 0.00
Celldex Therapeutics (CLDX) United States $0.029B 0.00
Evogene (EVGN) Israel $0.028B 0.00
TOCAGEN INC (TOCA) United States $0.028B 0.00
Celsion (CLSN) United States $0.025B 0.00
Curis (CRIS) United States $0.025B 0.00
Signal Genetics (MGEN) United States $0.025B 0.00
Entera Bio (ENTX) Israel $0.024B 0.00
BioCardia (BCDA) United States $0.023B 0.00
Pulmatrix (PULM) United States $0.023B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.023B 0.00
VistaGen Therapeutics (VTGN) United States $0.022B 0.00
Novogen (KZIA) Australia $0.021B 0.00
Cleveland BioLabs (CBLI) United States $0.020B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.020B 0.00
Stellar Biotechnologies (EDSA) Canada $0.019B 0.00
Apricus Biosciences (SEEL) United States $0.018B 0.00
Oncobiologics (OTLK) United States $0.018B 0.00
Titan Pharmaceuticals (TTNP) United States $0.018B 0.00
Alimera Sciences (ALIM) United States $0.018B 0.00
Bionano Genomics (BNGO) United States $0.016B 0.00
Aptevo Therapeutics (APVO) United States $0.013B 0.00
Unum Therapeutics (UMRX) United States $0.013B 0.00
AEterna Zentaris (AEZS) United States $0.012B 0.00
ATyr Pharma (LIFE) United States $0.011B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
TrovaGene (TROV) United States $0.011B 0.00
VIVUS (VVUS) United States $0.010B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
Cesca Therapeutics (THMO) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
TRACON Pharmaceuticals (TCON) United States $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.006B 0.00
IMMURON (IMRN) Australia $0.006B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Spherix (AIKI) United States $0.003B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00